The role of sleep disorders in cardiovascular diseases: Culprit or accomplice?

Life Sci. 2021 Oct 15:283:119851. doi: 10.1016/j.lfs.2021.119851. Epub 2021 Jul 26.

Abstract

Sleep disorders frequently comorbid with several cardiovascular diseases (CVDs), attracting increasing scientific attention and interest. Sleep disorders include insomnia, sleep-disordered breathing, restless legs syndrome, etc. It is well known that inflammation, sympathetic activation, and endothelial dysfunction play critical roles in sleep disorders, all of which are predisposing factors for CVDs. The comorbidity of sleep disorders and CVDs may have a bidirectional relationship. Patients with CVDs may have a high incidence of sleep disorders and vice versa. This review focused on the comorbidity of sleep disorders and CVDs and discussed the potential pathophysiological mechanisms and therapeutic strategies. In addition to the existing mechanisms, this review summarized novel potential mechanisms underlying comorbidities, such as gut microbiota, orexin, and extracellular vesicles, which may provide a theoretical basis for further basic research and clinical investigations on improving therapeutic outcomes.

Keywords: Cardiovascular diseases; Comorbidity; Extracellular vesicles; Gut microbiome; Orexin; Sleep disorders.

Publication types

  • Review

MeSH terms

  • Cardiovascular Diseases* / etiology
  • Cardiovascular Diseases* / metabolism
  • Cardiovascular Diseases* / microbiology
  • Cardiovascular Diseases* / therapy
  • Extracellular Vesicles / metabolism
  • Gastrointestinal Microbiome*
  • Humans
  • Orexins / metabolism
  • Sleep Wake Disorders* / complications
  • Sleep Wake Disorders* / metabolism
  • Sleep Wake Disorders* / microbiology
  • Sleep Wake Disorders* / therapy

Substances

  • Orexins